Skip to content
Review

Experience of large-scale AMH screening within the “Becoming a Mother” project in Moscow: integrating ovarian reserve testing into outpatient practice

2026 · Voprosy ginekologii akušerstva i perinatologii · Vol 25, pp. 5-13 · 0 citations

TL;DR

The Moscow project represents an innovative experience in integrating ovarian reserve assessment into primary health care and contribute significantly to understanding the population-level epidemiology of reproductive health and open up prospects to improve medical care for reproductive-aged women.

Abstract

Declining birth rates in large cities and delayed motherhood require innovative approaches to maintaining the population’s reproductive health. The “Becoming a Mother” project (Moscow, 2024–2025) provides a unique experience of integrating anti-Müllerian hormone (AMH) screening into outpatient obstetrics and gynecology care. Objective. To present the results of large-scale AMH screening and analyze its clinical significance in the context of current data on the epidemiology of AMH level trends and strategies for preserving reproductive health. Materials and methods. A systematic review of literature for the period from 2020 to 2025 was conducted, along with an analysis of data from the “Becoming a Mother” project, in which 254,948 women who underwent AMH testing between September 9, 2024, and August 31, 2025, participated. Results. Distribution of results: AMH <1.2 ng/mL was observed in 19.5% of study participants; AMH 1.2–1.49 in 6.3%; and AMH ≥1.5 in 74.2%. Among women with AMH >20 ng/mL, polycystic ovary syndrome was diagnosed in 44.3% of cases, allowing timely initiation of treatment. A total of 11,071 women were referred to a gynecologist, and 658 women underwent oocyte cryopreservation (849 oocytes and 197 embryos were vitrified). The program demonstrated high efficacy in the timely detection of diseases and provided access to advanced reproductive technologies. Conclusion. The Moscow project represents an innovative experience in integrating ovarian reserve assessment into primary health care. The scale of the program and the data obtained contribute significantly to understanding the population-level epidemiology of reproductive health and open up prospects to improve medical care for reproductive-aged women. Key words: anti-Müllerian hormone, ovarian reserve, reproductive health, fertility preservation, preventive medicine, population policy

View source

Similar papers

Open access 2026

Ovarian Reserve in Women of the Moscow Metropolis: First National Centile References for Anti Müllerian Hormone

For the first time, AMH centile reference values have been derived in a large non‑selective Russian population and are applicable to the individual assessment of ovarian reserve in clinical practice and to informed planning of reproductive behaviour.

V. E. Radzinsky, A. Olenev, S. Gadzhieva et al. · 0 citations
Open access 2026

Newborn Screening in Bisha region, Saudi Arabia: A 14 Years Retrospective Study on the Incidence of Inborn Errors of Metabolism and Comparisons with Regional and Global Data

Background: Newborn screening (NBS) is a population-based public health program designed to identify newborns with serious but treatable inborn error of metabolism disorders before the onset of clinical symptoms. Early diagnosis through NBS enables timely intervention, thereby reducing morbidity, mortality, and long-te...

E. Ziad, B. Kayode-Adedeji, Nafiu Liadi · 0 citations
Open access Sep 2026

Anti-Müllerian hormone is a poor predictor of pregnancy with and without assisted reproductive technology: A population-based register study of 43,269 Danish women.

OBJECTIVE Anti-Müllerian hormone (AMH) is widely used as a marker of ovarian reserve, but its predictive value for pregnancy remains uncertain. We aimed to evaluate whether pre-pregnancy AMH predicts pregnancy with or without assisted reproductive technology (ART). MATERIALS AND METHODS This population-based register...

Maja Vigstedt, Freja Rueholm Klok, L. Prætorius et al. · 0 citations
Review Open access Oct 2026

Healthcare professionals' views on expanding newborn screening with or without genomics in France: Results of the SeDeN-p2 study.

Therapeutic advances and the rapid, cost-effective development of next-generation sequencing (NGS) have increased interest in expanding newborn screening (NBS) through genomics. The SeDeN-p2 study assessed the acceptability among healthcare professionals in France, of expanding NBS, particularly with genetics as a firs...

Camille Level, Frédéric Huet, Dominique Salvi et al. · 0 citations
Aug 2026

Incidence and clinical distribution of congenital hypothyroidism in Bolu Province, Türkiye: a four-year analysis of the National Newborn Screening Program

The incidence of CH and the recall rate in Bolu were higher than those reported in iodine-sufficient countries, and relatively high proportion of transient CH warrants further investigation of regional iodine status.

S. Bolu, F. Bolu, Yasemin Baranoğlu Kılınç · 0 citations
Review Aug 2026

Chagas Screening Among Active-Duty Servicewomen with a History of Pregnancy.

The demographic factors associated with CD screening among active-duty servicewomen (ADSW) born in endemic countries, with and without a reported history of pregnancy are described, reflecting a gap in implementation of current recommendations.

Joshua W. Trowell, A. Michel, Anwar E. Ahmed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.